Accelerating Cell and Gene Therapy Development with Ori Biotech and Charles River Laboratories
Wednesday, 18 September 2024, 05:30
Partnership Overview
Ori Biotech, a leader in cell therapy manufacturing, has joined forces with Charles River Laboratories to expedite cell and gene therapy development. This collaboration signifies a major step forward in the production of life-saving therapies, utilizing the innovative IRO® cell therapy manufacturing platform.
Key Features of the IRO® Platform
- Enhanced Efficiency: Streamlining production processes for quicker delivery of therapies.
- Improved Quality Control: Ensuring high standards in manufacturing.
- Scalability: Addressing the growing demand for cell and gene therapies.
Impact on the Medical Industry
This collaboration is poised to transform the landscape of cell and gene therapy. By combining expertise from both organizations, they aim to facilitate access to critical treatments for patients globally.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.